CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$192M
1-Year Return
17.05%
This Quarter Return
+12.59%
1 Year Return
+17.05%
3 Year Return
+45.89%
5 Year Return
+105.96%
10 Year Return
+138.93%
AUM
$611M
AUM Growth
+$61.5M
(+11%)
Cap. Flow
+$7.82M
Cap. Flow
% of AUM
1.28%
Top 10 Holdings %
Top 10 Hldgs %
8.42%
Holding
675
New
112
Increased
203
Reduced
170
Closed
94
Top Buys
| 1 |
Chevron
CVX
|
+$3.49M |
| 2 |
Align Technology
ALGN
|
+$2.71M |
| 3 |
Broadcom
AVGO
|
+$2.22M |
| 4 |
LyondellBasell Industries
LYB
|
+$2.03M |
| 5 |
Atlassian
TEAM
|
+$2.03M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
+$5.51M |
| 2 |
Kinder Morgan
KMI
|
+$2.94M |
| 3 |
Walt Disney
DIS
|
+$2.71M |
| 4 |
VMW
VMware, Inc
VMW
|
+$2.56M |
| 5 |
Pfizer
PFE
|
+$2.49M |
Sector Composition
| 1 | Technology | 18.17% |
| 2 | Financials | 18.09% |
| 3 | Healthcare | 13.8% |
| 4 | Industrials | 12.97% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Intuit
INTU
$183B
| $366K | 0.06% |
585
| – | – |
|
477
Shattuck Labs
STTK
$83.8M
| $363K | 0.06% |
50,973
| – | – |
|
478
Synopsys
SNPS
$71.8B
| $361K | 0.06% |
702
-5
| -0.7% | -$2.58K |
|
479
Advanced Micro Devices
AMD
$259B
| $355K | 0.06% |
2,408
| – | – |
|
480
Core Molding Technologies
CMT
$180M
| $352K | 0.06% |
19,005
| – | – |
|
481
Allstate
ALL
$52.7B
| $350K | 0.06% |
2,497
| – | – |
|
482
Coca-Cola
KO
$292B
| $348K | 0.06% |
5,907
-208
| -3% | -$12.3K |
|
483
Gray Television
GTN
$579M
| $342K | 0.06% |
38,148
+445
| +1% | +$3.99K |
|
484
Charles River Laboratories
CRL
$7.54B
| $339K | 0.06% |
1,434
-412
| -22% | -$97.4K |
|
485
Commercial Vehicle Group
CVGI
$70.3M
| $315K | 0.05% |
44,986
+1,090
| +2% | +$7.64K |
|
486
InMode
INMD
$949M
| $312K | 0.05% |
14,021
+352
| +3% | +$7.83K |
|
487
Herbalife
HLF
$958M
| $296K | 0.05% |
19,416
| – | – |
|
488
Amphenol
APH
$145B
| $294K | 0.05% |
5,940
| – | – |
|
489
MacroGenics
MGNX
$109M
| $280K | 0.05% |
29,110
-6,233
| -18% | -$60K |
|
490
Principal Financial Group
PFG
$17.8B
| $278K | 0.05% |
3,535
| – | – |
|
491
Arvinas
ARVN
$575M
| $277K | 0.05% |
+6,727
| New | +$277K |
|
492
Kymera Therapeutics
KYMR
$3.11B
| $275K | 0.05% |
10,806
+53
| +0.5% | +$1.35K |
|
493
Amkor Technology
AMKR
$6.13B
| $275K | 0.04% |
+8,255
| New | +$275K |
|
|
DCPH
494
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $269K | 0.04% |
16,673
+3,294
| +25% | +$53.1K |
|
|
PSTX
495
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $267K | 0.04% |
79,552
-157
| -0.2% | -$528 |
|
496
Zymeworks
ZYME
$1.15B
| $267K | 0.04% |
25,709
-46
| -0.2% | -$478 |
|
497
Tenaya Therapeutics
TNYA
$212M
| $263K | 0.04% |
81,255
+46,847
| +136% | +$152K |
|
498
C4 Therapeutics
CCCC
$188M
| $262K | 0.04% |
46,286
-1,170
| -2% | -$6.61K |
|
|
499
Kinder Morgan
KMI
$60.8B
| $261K | 0.04% |
14,822
-166,829
| -92% | -$2.94M |
|
500
Iovance Biotherapeutics
IOVA
$861M
| $257K | 0.04% |
31,657
-57
| -0.2% | -$463 |
|